MiNA Therapeutics
Develops small activating RNA medicines that switch on the body's own genes, with a pipeline starting in genetic medicine.
minatx.com ↗Why it's here
Its first RNAa medicine has been tested in clinical trials with more than 130 patients, and it signed a research collaboration with Nippon Shinyaku in April 2024.
source: minatx.com- Focus
- RNA therapeutics
- Founded
- 2008
- Latest round
- Series A, $30M, Sep 2020
- London office
- Translation & Innovation Hub, 84 Wood Lane, London, Hammersmith and Fulham W12 0BZsource: minatx.com
- London presence
- HQsource: minatx.com
- Investors
- aMoon (lead)source: biospace.com
- Nearest station
- White City, 424 m
- Visas
- Licensed visa sponsor, listed as MiNA Therapeutics Limitedsource: gov.uk
Verified 8 Oct 2026. How we verify · Suggest a fix
Same building
3 more companies on the map list this office address.